APPLICABILITY OF RISK OF MALIGNANCY INDEX IV FOR SCREENING MALIGNANT OVARIAN MASS AMONG PATIENT WITH ADNEXAL MASS AND ITS COMPARISION WITH OTHER RISK OF MALIGNANCY INDEXES.

Journal Title: International Journal of Advanced Research (IJAR) - Year 2018, Vol 6, Issue 10

Abstract

Background: Adnexal masses are common gynaecological conditions and might be encountered at every stage of a woman life. As presentation of ovarian cancer is very vague ovarian malignancies are called as ?SILENT KILLERS?. So patients presenting with adnexal mass needs to be preoperatively evaluated and screened for malignancy. Risk of Malignancy Index(RMI) is a combination screening method which utilises menopausal status, CA125 level and ultrasound findings to predict whether an adnexal mass is benign or malignant. Aim and Objective: The aim of the study is to evaluate the ability of RMI 4 to discriminate between benign and malignant adnexal mass and to compare it with RMI1, RMI2 and RMI3. MATERIAL AND METHODS- It is a prospective study done over a period from July 2015 to January 2018. Total 124 patients were included in study. Data regarding menopausal status, ultrasound features, size of lesion and CA125level were collected. RMI4 was calculated for each patient. Collected data was analyzed by comparing the means and the differences between groups and assessed with Student?s t test and ?2 test where necessary. Result: In present study, RMI4 was found to be a statistically significant as a screening agent for discriminating benign from malignant adnexal mass. The cut off value for RMI4 was found to be 450 with sensitivity, specificity, positive predictive value of 68.3%, 84.4% and 80.4% respectively. When comparing effectiveness of RMI4 with other RMIs; RMI4 had a higher specificity compared to others like RMI1(82.8%), RMI2(82.8%) and RMI3(81.3%) but sensitivity of RMI2 (70%) is more than RMI4(68.3%). Conclusion: Ovarian cancer has become fourth most common cancer in India. India being a low resource country, identification of a malignant lesion at peripheral level pre-operatively will help in prompt referral to gynecological oncology centers.

Authors and Affiliations

Smrutishree Sahoo, Sujata Singh, Lucy Das, Sasmita Swain.

Keywords

Related Articles

HIGHER EDUCATION ACCESSIBILITY AND FINANCIAL SUSTAINABILITY IN GHANA: THE ROLE OF THE STUDENT LOAN SCHEME.

Higher education has been recognized as the process leading to the development of human capital which determines the path of economic development. As a result, the financing of higher education has been a national priori...

SCREENING, ISOLATION AND MOLECULAR IDENTIFICATION OF RICE PATHOGEN MAGNAPORTHE ORYZAE.

Rice, a major food crop and feeds more than half of the world?s population, mainly in developing countries including Asia and Africa. Magnaportheoryzae, a Blast pathogen attacks rice at any stage of its life cycle. Blast...

?ASSESS THE KNOWLEDGE ON PREVENTION OF HEPATITIS B AMONG IVTH CLASS WORKERS OF SELECTED URBAN HEALTH CENTRES.?

The study was to assess the knowledge regarding prevention of hepatitis B among the IVth class workers of selected urban heath centers of Sangli, Miraj and Kupwad corporation area. The quantitative research approach was...

HIP MUSCLES TORQUE IN RUNNERS WITH MEDIAL TIBIAL STRESS SYNDROME.

Background: Medial tibial stress syndrome also called shin splints; the incidence ranges 4-35% in athletic& military populations present with medial tibial stress syndrome .Pain at posteromedial tibia. The pain is cumula...

OZONE AN ENDODONTIC BLISS: A REVIEW.

Ozonated water is recognized to have an antiseptic, powerful oxidative and strong antimicrobial property towards bacteria, fungi, viruses and protozoa. Endodontics is mainly concerned about thorough root canal disinfecti...

Download PDF file
  • EP ID EP409554
  • DOI 10.21474/IJAR01/7813
  • Views 55
  • Downloads 0

How To Cite

Smrutishree Sahoo, Sujata Singh, Lucy Das, Sasmita Swain. (2018). APPLICABILITY OF RISK OF MALIGNANCY INDEX IV FOR SCREENING MALIGNANT OVARIAN MASS AMONG PATIENT WITH ADNEXAL MASS AND ITS COMPARISION WITH OTHER RISK OF MALIGNANCY INDEXES.. International Journal of Advanced Research (IJAR), 6(10), 326-331. https://europub.co.uk/articles/-A-409554